Showing papers in "The Journal of Pain in 2015"

TL;DR: Self-reported pain in U.S. adults was described and individuals with category 3 or 4 pain were likely to have worse health status, to use more health care, and to suffer from more disability than those with less severe pain.

TL;DR: The historical context and beginnings of Explaining Pain are described, suggesting that it is a pragmatic application of the biopsychosocial model of pain, but differentiating it from cognitive behavioral therapy and educational components of early multidisciplinary pain management programs.

TL;DR: There was a higher rate of adverse events among cannabis users compared with controls but not for serious adverse events at an average dose of 2.5 g herbal cannabis per day, which appears to have a reasonable safety profile.

TL;DR: This novel Bayesian meta-analysis of individual patient data from 5 randomized trials suggests that inhaled cannabis may provide short-term relief for 1 in 5 to 6 patients with neuropathic pain.

TL;DR: This small, short-term, placebo-controlled trial of inhaled cannabis demonstrated a dose-dependent reduction in diabetic peripheral neuropathy pain in patients with treatment-refractory pain, adding preliminary evidence to support further research on the efficacy of the cannabinoids in neuropathic pain.

TL;DR: The PSEQ-2 appears to be a robust measure of pain self-efficacy and suitable for use in clinical and research settings, and its validity and internal consistency were found to be sound.

TL;DR: Findings indicate that affective, anxiety, and behavior disorders are early risk factors of chronic pain, thereby highlighting the relevance of child mental disorders for pain medicine.

TL;DR: This study demonstrates that using both indicators of pharmacy shopping and overlapping opioid prescriptions will better identify those at high risk of overdose, the first step in implementing targeted prevention policies.

TL;DR: In this article, the authors examined the influence of patient race, provider racial bias, and clinical ambiguity on pain management decisions and suggested that interventions to reduce disparities should differentially target patient, provider, and contextual factors.

TL;DR: Accumulated results like these suggest that acceptance of pain may be a general mechanism by which CBT-based treatments achieve improvements in functioning, and more specific targeting of pain-related acceptance in treatment may lead to further improvements in outcome.

TL;DR: Findings lend support to the hypothesis that patients may be self-medicating affective pain with opioids, as depression emerged as a moderator of the relationship among opioid use, pain severity, and physical functioning.

TL;DR: A form of placebo analgesia is demonstrated that relies on prior conditioning rather than current expected pain relief, suggesting that reinforcing treatment cues with positive outcomes can create placebo effects that are independent of reported expectations for pain relief.

TL;DR: Overall PGIC ratings appeared to be influenced to a greater degree by patients' experienced improvements in physical activities and mood than by improvements in pain, suggesting that in addition to a single overall PGIC rating, domain-specific items may be relevant for some treatment trials.

TL;DR: The data suggest that the SF-MPQ-2 can provide a valid, responsive, and efficient assessment of both neuropathic and nonneuropathic pain qualities for clinical trials and other clinical research examining patients with various acute and chronic pain conditions.

TL;DR: In conclusion, child anxiety, parental pain catastrophizing, and sleep patterns are potentially modifiable factors that predict poor outcomes in children after major surgery.

TL;DR: A bidirectional temporal association between depression and FMS such that each disease occurring first may increase the risk of the other subsequently subsequently is supported.

TL;DR: These findings provide the first evidence that individuals with preexisting impairments in mood and descending pain modulation may be at greater risk for developing chronic neck pain when exposed to peripheral nociceptive stimuli such as that produced during muscle fatigue.

TL;DR: It is shown that a 5-day treatment of motor cortex stimulation with tDCS can induce stable relief from PLP in amputees, and neuromodulation targeting the motor cortex appears to be a promising option for the management of this debilitating neuropathic pain condition.

TL;DR: The independent contributions of self-reported ratings of pain intensity, sleep disturbance, depression, and fatigue to ratings of physical function and pain-related interference in a diverse sample of treatment-seeking individuals with chronic pain are characterized.

TL;DR: It is concluded that the HADS is a valid instrument for efficient, low-burden assessment of anxiety and depression in clinical trials with an acute low back pain population.

TL;DR: It was found that surgery and physical manual therapies including desensitization maneuvers of the central nervous system were similarly effective at medium-term and long-term follow-ups for improving pain and function but that physical therapy led to better outcomes in the short term.

TL;DR: Findings suggest that once established, nocebo hyperalgesia may be difficult to disrupt and partial reinforcement may serve as a method for reducing the intensity of nocebos intensity in the clinic, which may be particularly important given its persistence.

TL;DR: An automated surveillance method utilizing baseline risk indicators from structured EHR data was moderately accurate in identifying COT patients who had subsequent problem opioid use, as well as comparably predictive of the natural language processing measure of problem opioids use.

TL;DR: Altered connectivity patterns associated with high pain experience in patients with sickle cell disease suggest a possible role of central mechanisms in Sickle cell pain and resting state brain connectivity studies should be explored as an effective methodology to investigate pain in SCD.

TL;DR: A systematic review of published prospective studies reporting adverse events of morphine, oxycodone, fentanyl, methadone, or hydromorphone for cancer-related pain in patients naive for these opioids finds a large heterogeneity among included studies, especially regarding the assessment and reporting of AEs.

TL;DR: The findings provide the rationale for the development of psychological or neurofeedback-based techniques aimed at modifying patients' negative affect and cognitions toward pain, and highlight the presence of alterations in pain-anticipatory brain activity in FM.

TL;DR: It appears that reduced conscious attention toward incoming stimuli, resulting from dissociation, causes delayed response in pain threshold measurement, whereas biases toward threatening stimuli and decreased inhibition are responsible for the intensification of experimental and chronic pain.

TL;DR: The findings are consistent with previous literature indicating an association between thermal perception and cortical thickness in brain regions involved in somatosensation, cognition, and salience detection and caregivers and clinicians should consider cognitive ability when assessing and managing pain in adolescents with ASD.

TL;DR: This article demonstrates that targeted dietary manipulation can alter endocannabinoids derived from omega-3 and omega-6 fatty acids and that these changes are related to reductions in headache pain and psychological distress and suggests that 2-docosahexaenoylglycerol and docosa hexaenoylethanolamine could have physical and/or psychological pain modulating properties.

TL;DR: AlthoughHRQOL returns to the baseline level for most children, a sizeable proportion have significant deterioration in HRQOL associated with continued postsurgical pain at 1 month after hospital discharge from surgery, addressing an important gap in the literature.